Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Years
Clinical trial NCT00825162 · COMPLETED
Trial details
- NCT number
- NCT00825162
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2010-02-01
- Enrollment
- 1992
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.